vs

Side-by-side financial comparison of Criteo S.A. (CRTO) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.

Criteo S.A. is the larger business by last-quarter revenue ($482.7M vs $382.2M, roughly 1.3× LifeStance Health Group, Inc.). Criteo S.A. runs the higher net margin — 4.4% vs 3.1%, a 1.3% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 2.4%). LifeStance Health Group, Inc. produced more free cash flow last quarter ($46.6M vs $-36.6M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs 1.4%).

Criteo S.A. is an advertising company that provides online display advertisements. The company was founded and is headquartered in Paris, France.

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

CRTO vs LFST — Head-to-Head

Bigger by revenue
CRTO
CRTO
1.3× larger
CRTO
$482.7M
$382.2M
LFST
Growing faster (revenue YoY)
LFST
LFST
+15.0% gap
LFST
17.4%
2.4%
CRTO
Higher net margin
CRTO
CRTO
1.3% more per $
CRTO
4.4%
3.1%
LFST
More free cash flow
LFST
LFST
$83.3M more FCF
LFST
$46.6M
$-36.6M
CRTO
Faster 2-yr revenue CAGR
LFST
LFST
Annualised
LFST
12.8%
1.4%
CRTO

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CRTO
CRTO
LFST
LFST
Revenue
$482.7M
$382.2M
Net Profit
$21.3M
$11.7M
Gross Margin
53.6%
Operating Margin
6.3%
4.7%
Net Margin
4.4%
3.1%
Revenue YoY
2.4%
17.4%
Net Profit YoY
-21.3%
264.1%
EPS (diluted)
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRTO
CRTO
LFST
LFST
Q4 25
$382.2M
Q3 25
$363.8M
Q2 25
$482.7M
$345.3M
Q1 25
$451.4M
$333.0M
Q4 24
$553.0M
$325.5M
Q3 24
$458.9M
$312.7M
Q2 24
$471.3M
$312.3M
Q1 24
$450.1M
$300.4M
Net Profit
CRTO
CRTO
LFST
LFST
Q4 25
$11.7M
Q3 25
$1.1M
Q2 25
$21.3M
$-3.8M
Q1 25
$37.9M
$709.0K
Q4 24
$71.1M
$-7.1M
Q3 24
$6.2M
$-6.0M
Q2 24
$27.0M
$-23.3M
Q1 24
$7.2M
$-21.1M
Gross Margin
CRTO
CRTO
LFST
LFST
Q4 25
Q3 25
Q2 25
53.6%
Q1 25
52.5%
Q4 24
54.4%
Q3 24
50.5%
Q2 24
49.4%
Q1 24
48.3%
Operating Margin
CRTO
CRTO
LFST
LFST
Q4 25
4.7%
Q3 25
2.0%
Q2 25
6.3%
-0.9%
Q1 25
10.7%
0.5%
Q4 24
17.1%
0.3%
Q3 24
2.1%
0.0%
Q2 24
7.8%
-5.1%
Q1 24
2.3%
-5.6%
Net Margin
CRTO
CRTO
LFST
LFST
Q4 25
3.1%
Q3 25
0.3%
Q2 25
4.4%
-1.1%
Q1 25
8.4%
0.2%
Q4 24
12.9%
-2.2%
Q3 24
1.4%
-1.9%
Q2 24
5.7%
-7.5%
Q1 24
1.6%
-7.0%
EPS (diluted)
CRTO
CRTO
LFST
LFST
Q4 25
Q3 25
Q2 25
$0.39
Q1 25
$0.66
Q4 24
$1.21
Q3 24
$0.11
Q2 24
$0.46
Q1 24
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRTO
CRTO
LFST
LFST
Cash + ST InvestmentsLiquidity on hand
$223.6M
$248.6M
Total DebtLower is stronger
$282.8M
Stockholders' EquityBook value
$1.1B
$1.5B
Total Assets
$2.1B
$2.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRTO
CRTO
LFST
LFST
Q4 25
$248.6M
Q3 25
$203.9M
Q2 25
$223.6M
$188.9M
Q1 25
$313.2M
$134.3M
Q4 24
$316.9M
$154.6M
Q3 24
$231.8M
$102.6M
Q2 24
$233.2M
$87.0M
Q1 24
$278.1M
$49.5M
Total Debt
CRTO
CRTO
LFST
LFST
Q4 25
$282.8M
Q3 25
$284.6M
Q2 25
$286.4M
Q1 25
$288.2M
Q4 24
$290.0M
Q3 24
$287.3M
Q2 24
$288.0M
Q1 24
$288.8M
Stockholders' Equity
CRTO
CRTO
LFST
LFST
Q4 25
$1.5B
Q3 25
$1.5B
Q2 25
$1.1B
$1.5B
Q1 25
$1.1B
$1.5B
Q4 24
$1.0B
$1.4B
Q3 24
$1.1B
$1.4B
Q2 24
$1.0B
$1.4B
Q1 24
$1.0B
$1.4B
Total Assets
CRTO
CRTO
LFST
LFST
Q4 25
$2.2B
Q3 25
$2.1B
Q2 25
$2.1B
$2.1B
Q1 25
$2.1B
$2.1B
Q4 24
$2.3B
$2.1B
Q3 24
$2.2B
$2.1B
Q2 24
$2.2B
$2.1B
Q1 24
$2.2B
$2.1B
Debt / Equity
CRTO
CRTO
LFST
LFST
Q4 25
0.19×
Q3 25
0.19×
Q2 25
0.19×
Q1 25
0.20×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.20×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRTO
CRTO
LFST
LFST
Operating Cash FlowLast quarter
$-1.4M
$57.6M
Free Cash FlowOCF − Capex
$-36.6M
$46.6M
FCF MarginFCF / Revenue
-7.6%
12.2%
Capex IntensityCapex / Revenue
7.3%
2.9%
Cash ConversionOCF / Net Profit
-0.07×
4.93×
TTM Free Cash FlowTrailing 4 quarters
$110.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRTO
CRTO
LFST
LFST
Q4 25
$57.6M
Q3 25
$27.3M
Q2 25
$-1.4M
$64.4M
Q1 25
$62.3M
$-3.1M
Q4 24
$169.5M
$62.3M
Q3 24
$57.5M
$22.7M
Q2 24
$17.2M
$44.1M
Q1 24
$14.0M
$-21.8M
Free Cash Flow
CRTO
CRTO
LFST
LFST
Q4 25
$46.6M
Q3 25
$17.0M
Q2 25
$-36.6M
$56.6M
Q1 25
$45.3M
$-10.3M
Q4 24
$56.0M
Q3 24
$17.7M
Q2 24
$-4.0M
$39.0M
Q1 24
$173.0K
$-26.9M
FCF Margin
CRTO
CRTO
LFST
LFST
Q4 25
12.2%
Q3 25
4.7%
Q2 25
-7.6%
16.4%
Q1 25
10.0%
-3.1%
Q4 24
17.2%
Q3 24
5.7%
Q2 24
-0.9%
12.5%
Q1 24
0.0%
-9.0%
Capex Intensity
CRTO
CRTO
LFST
LFST
Q4 25
2.9%
Q3 25
2.8%
Q2 25
7.3%
2.2%
Q1 25
3.8%
2.2%
Q4 24
1.9%
Q3 24
1.6%
Q2 24
4.5%
1.6%
Q1 24
3.1%
1.7%
Cash Conversion
CRTO
CRTO
LFST
LFST
Q4 25
4.93×
Q3 25
25.34×
Q2 25
-0.07×
Q1 25
1.64×
-4.36×
Q4 24
2.38×
Q3 24
9.21×
Q2 24
0.64×
Q1 24
1.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRTO
CRTO

Commerce Growth$393.9M82%
Retail Media$60.9M13%
Other$27.9M6%

LFST
LFST

Segment breakdown not available.

Related Comparisons